Powder for solution for injection 500mg

Inhalation vapour 250ml

Inhalation gas cylinders.

For analgesia (without loss of consciousness), manufacturer advises a mixture of nitrous oxide and oxygen containing 50% of each gas (Entonox®) is used.

Inhalation vapour 250ml

Injection 600micrograms/1mL
Injection prefilled syringe 500micrograms in 5mL, 1mg in 5mL, 1mg in 10mL, 3mg in 10mL

Injection 200micrograms/1mL, 600micrograms/3mL

Injection 10mg/2mL

Injection 4mg/1mL

Injection 5mg/5ml

NB. The 10mg/2ml injection is for use in palliative care only. Please see Palliative Care formulary.

NHS Never Event: Mis-selection of high-strength midazolam during conscious sedation (January 2018).
In clinical areas performing conscious sedation, high-strength preparations (5 mg/mL in 2 mL and 10 mL ampoules, or 2 mg/mL in 5 mL ampoules) should not be selected in place of the 1 mg/mL preparation.

The areas where high-strength midazolam is used should be restricted to those performing general anaesthesia, intensive care, palliative care, or areas where its use has been formally risk-assessed in the organisation. In these situations the higher strength may be more appropriate to administer the prescribed dose.

It is advised that flumazenil is available when midazolam is used, to reverse the effects if necessary.

Midazolam 40mg/Lidocaine 20mg/1mL nasal solution,
Midazolam 20mg/Lidocaine 10mg/0.5mL nasal solution

For paediatric surgical use only

 Unlicensed

Injection 30mg/1mL

Injection 5mg/10mL, 1mg/2mL
Intensive care injection 5mg/1mL

Injection 500micrograms/10mL, 100 micrograms/2mL

Injection 1mg, 2mg, 5mg 

Injection 150microgram/mL

Injection 100micrograms/mL 2mL & 4mL ampoules

Dexmedetomidine should only be administered by, or under the direct supervision of, personnel experienced in its use, with adequate training in anaesthesia and airway management.

Injection 10mg/5mL

Injection 10mg/1mL

Injection 10mg

Injection 100mg/2mL

Injection glycopyrronium 2.5mg / neostigmine 500micrograms/1ml

Injection 200mg/2ml, 500mg/5ml

Routine reversal of neuromuscular blockade induced by rocuronium or vecuronium.

Injection 100mg/5ml

Injection 500micrograms/5ml

Flumazenil should only be administered by, or under the direct supervision of, personnel experienced in its use.

Injection 400micrograms/1ml
Pre-filled syringe 2mg/2ml

Doses used in acute opioid overdose may not be appropriate when there is risk of acute withdrawal (e.g. chronic opioid use), or when a continued therapeutic effect is required (e.g. postoperative use, palliative care).

Injection 120mg vial

Injection 40mg/mL with 1 in 200,000 and 40mg/mL with 1 in 100,000

Injection 0.25%, 0.5% 10mL
Infusion 0.1%, 0.125% 250ml

Injection bupivacaine 5mg/mL / glucose 80mg/mL 4mL

Epidural infusion fentanyl 2micrograms/mL, bupivacaine 0.1% 500mL

Infusion 1.25mg/mL 100mL & 200ml
Injection, 2.5mg/mL, 5mg/mL and 7.5mg/mL

Epidural

 Unlicensed

Injection 0.5%, 1%, 2% 

Plasters 5% (700mg/medicated plaster)

See chapter 4 

Injection 1% / 1:200,000 20mL
Injection 2% / 1:200,000 20mL

Injection 2% / 1:80,000 2mL cartridge (for dental use)

Lidocaine 5%/Phenylephrine 0.5% nasal spray

Lidocaine 25mg/1g, Prilocaine 25mg/1g cream

 for licensed indications.

 for specific indications within hospital Trusts, including:
MBHT - for use in theatres for grommet insertion (unlicensed use).
ELHT - to help with irritation caused by use of Aldara cream in women with Vulval intraepithelial neoplasia.

Injection 30mg/1mL

Prilocaine hydrochloride (Prilotekal®) in glucose injection 20mg/mL
Prilocaine Hydrochloride (Citanest®) injection 1%
Prilocaine Hydrochloride with Felypressin (Citanest with Octapressin®) 3% prilocaine
hydrochloride and 0.54 micrograms/mL felypressin

Injection 50mg/5mL

Injection 2mg/mL, 7.5mg/mL, 10mg/mL Infusion 2mg/mL

Gel 4% 1.5g tube

Spray

To provide a sensory cold sensation to check spinal and epidural anaesthesia blocks.